Correspondence

Advice on Epidyolex

Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.

• From: Advisory Council on the Misuse of Drugs
• Published: 29 January 2020

Documents

Advice on Epidyolex (accessible version)

HTML

Advice on Epidyolex

PDF, 187 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The ACMD Chair, Professor Owen Bowden-Jones, and the ACMD’s Technical Committee Chair, Professor Roger Knaggs, write to the Minister of State for Crime, Policing and the Fire Service. They recommend that it would be most appropriate for Epidyolex, a cannabis-based product for medicinal use (CBPM), to be placed in Schedule 5 under the Misuse of Drugs Regulations 2001.

You can read the letter from the from the Minister of State for Fire and Policing to the ACMD, in response to the recommendation to Schedule Epidyolex.

Published 29 January 2020